SUPERNUS PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Supernus Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $26.1M, a 11.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $26.1M -$3.37M -11.4% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $27.8M -$1.38M -4.73% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $29.7M -$274K -0.91% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $29M +$90K +0.31% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $29.5M -$207K -0.7% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $29.1M -$1.49M -4.87% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $30M -$2.12M -6.59% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $28.9M -$6.46M -18.3% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 $29.7M -$445K -1.48% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $30.6M +$971K +3.27% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $32.1M +$11.3M +54.5% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $35.4M +$15.1M +74.8% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $30.1M +$9.09M +43.2% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $29.7M +$8.38M +39.3% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $20.8M -$1.1M -5.03% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $20.2M -$1.05M -4.93% Dec 31, 2020 10-K 2022-04-13
Q3 2020 $21M +$2.24M +11.9% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $21.3M +$1.65M +8.4% Jun 30, 2020 10-Q 2020-08-17
Q1 2020 $21.9M +$1.86M +9.29% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $21.3M Dec 31, 2019 10-K 2021-03-08
Q3 2019 $18.8M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $19.6M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $20M Mar 31, 2019 10-Q 2019-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.